
UB408
TargetsBCMA/CD3
IndicationsMultiple myeloma; Primary amyloidosis
ClinicalCN - I
TherapeuticsOncology
ModalitiesAntibody
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →